Investigation of Brain Iron in Niemann-Pick Type C: A 7T Quantitative Susceptibility Mapping Study

References

1. 1.↵
   1. Rego T,
   2. Farrand S,
   3. Goh AM, et al

   . Psychiatric and cognitive symptoms associated with Niemann-Pick Type C disease: neurobiology and management. CNS Drugs 2019;33:125–42 doi:10.1007/s40263-018-0599-0 pmid:30632019

   CrossRefPubMed
2. 2.↵
   1. Adibhatla RM,
   2. Hatcher JF

   . Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2010;12:125–69 doi:10.1089/ars.2009.2668 pmid:19624272

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Fu R,
   2. Yanjanin NM,
   3. Bianconi S, et al

   . Oxidative stress in Niemann-Pick disease, type C. Mol Genet Metab 2010;101:214–18 doi:10.1016/j.ymgme.2010.06.018 pmid:20667755

   CrossRefPubMed
4. 4.↵
   1. Vázquez MC,
   2. Balboa E,
   3. Alvarez AR, et al

   . Oxidative stress: a pathogenic mechanism for Niemann-Pick Type C disease. Oxid Med Cell Longev 2012;2012:205713 doi:10.1155/2012/205713 pmid:22720116

   CrossRefPubMed
5. 5.↵
   1. Walterfang M,
   2. Di Biase MA,
   3. Cropley VL, et al

   . Imaging of neuroinflammation in adult Niemann-Pick type C disease: a cross-sectional study. Neurology 2020;94:e1716–25 doi:10.1212/WNL.0000000000009287 pmid:32209649

   Abstract/FREE Full Text
6. 6.↵
   1. Love S,
   2. Bridges LR,
   3. Case CP

   . Neurofibrillary tangles in Niemann-Pick disease type C. Brain J Neurol 1995;118:19–29 doi:10.1093/brain/118.1.119 pmid:7894998

   CrossRefPubMed
7. 7.↵
   1. Suzuki K,
   2. Parker CC,
   3. Pentchev PG, et al

   . Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol 1995;89:227–38 doi:10.1007/BF00309338 pmid:7754743

   CrossRefPubMed
8. 8.↵
   1. Villemagne VL,
   2. Velakoulis D,
   3. Doré V, et al

   . Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study. Eur J Nucl Med Mol Imaging 2019;46:1132–38 doi:10.1007/s00259-019-4273-7 pmid:30690666

   CrossRefPubMed
9. 9.↵
   1. Hare D,
   2. Ayton S,
   3. Bush A, et al

   . A delicate balance: iron metabolism and diseases of the brain. Front Aging Neurosci 2013;5:34 doi:10.3389/fnagi.2013.00034 pmid:23874300

   CrossRefPubMed
10. 10.↵
    1. Georgieff MK

    . The role of iron in neurodevelopment: fetal iron deficiency and the developing hippocampus. Biochem Soc Trans 2008;36:1267–71 doi:10.1042/BST0361267 pmid:19021538

    Abstract/FREE Full Text
11. 11.↵
    1. Donley DW,
    2. Realing M,
    3. Gigley JP, et al

    . Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington’s disease. PLoS One 2021;16:e0250606 doi:10.1371/journal.pone.0250606 pmid:33989290

    CrossRefPubMed
12. 12.↵
    1. Nnah IC,
    2. Wessling-Resnick M

    . Brain iron homeostasis: a focus on microglial iron. Pharmaceuticals (Basel) 2018;11:129 doi:10.3390/ph11040129 pmid:30477086

    CrossRefPubMed
13. 13.↵
    1. Ravanfar P,
    2. Loi SM,
    3. Syeda W, et al

    . Systematic review; quantitative susceptibility mapping (QSM) of brain iron profile in neurodegenerative diseases. Front Neurosci 2021;15:618435 doi:10.3389/fnins.2021.618435 pmid:33679303

    CrossRefPubMed
14. 14.↵
    1. Christomanou H,
    2. Kellermann J,
    3. Linke RP, et al

    . Deficient ferritin immunoreactivity in visceral organs from four patients with Niemann-Pick disease type C. Biochem Mol Med 1995;55:105–15 doi:10.1006/bmme.1995.1040 pmid:7582867

    CrossRefPubMed
15. 15.↵
    1. Christomanou H,
    2. Vanier MT,
    3. Santambrogio P, et al

    . Deficient ferritin immunoreactivity in tissues from Niemann-Pick type C patients: extension of findings to fetal tissues, H and L ferritin isoforms, but also one case of the rare Niemann-Pick C2 complementation group. Mol Genet Metab 2000;70:196–202 doi:10.1006/mgme.2000.3004 pmid:10924274

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Hung YH,
    2. Faux NG,
    3. Killilea DW, et al

    . Altered transition metal homeostasis in Niemann-Pick disease, type C1. Metallomics 2014;6:542–53 doi:10.1039/c3mt00308f pmid:24343124

    CrossRefPubMed
17. 17.↵
    1. Ladd ME,
    2. Bachert P,
    3. Meyerspeer M, et al

    . Pros and cons of ultra-high-field MRI/MRS for human application. Prog Nucl Magn Reson Spectrosc 2018;109:1–50 doi:10.1016/j.pnmrs.2018.06.001 pmid:30527132

    CrossRefPubMed
18. 18.↵
    1. Benussi A,
    2. Cotelli MS,
    3. Padovani A, et al

    . Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC. F1000Res 2018;7:194 doi:10.12688/f1000research.12361.1 pmid:29511534

    CrossRefPubMed
19. 19.↵
    1. Yushkevich PA,
    2. Piven J,
    3. Hazlett HC, et al

    . User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 2006;31:1116–28 doi:10.1016/j.neuroimage.2006.01.015 pmid:16545965

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Chakravarty MM,
    2. Steadman P,
    3. van Eede MC, et al

    . Performing label-fusion-based segmentation using multiple automatically generated templates. Hum Brain Mapp 2013;34:2635–54 doi:10.1002/hbm.22092 pmid:22611030

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Pauli WM,
    2. Nili AN,
    3. Tyszka JM

    . A high-resolution probabilistic in vivo atlas of human subcortical brain nuclei. Sci Data 2018;5:180063 doi:10.1038/sdata.2018.63 pmid:29664465

    CrossRefPubMed
22. 22.↵
    1. Fedorov A,
    2. Beichel R,
    3. Kalpathy-Cramer J, et al

    . 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 2012;30:1323–41 doi:10.1016/j.mri.2012.05.001 pmid:22770690

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Yaghmaie N,
    2. Syeda WT,
    3. Wu C, et al

    . QSMART: quantitative susceptibility mapping artifact reduction technique. Neuroimage 2021;231:117701 doi:10.1016/j.neuroimage.2020.117701 pmid:33484853

    CrossRefPubMed
24. 24.↵
    1. Jenkinson M,
    2. Beckmann CF,
    3. Behrens TE, et al

    . FSL. Neuroimage 2012;62:782–90 doi:10.1016/j.neuroimage.2011.09.015 pmid:21979382

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Li W,
    2. Wu B,
    3. Liu C

    . Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011;55:1645–56 doi:10.1016/j.neuroimage.2010.11.088 pmid:21224002

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Ng A,
    2. Johnston L,
    3. Chen Z, et al

    . Spatially dependent filtering for removing phase distortions at the cortical surface. Magn Reson Med 2011;66:784–93 doi:10.1002/mrm.22825 pmid:21394771

    CrossRefPubMed
27. 27.↵
    1. Fazlollahi A,
    2. Ayton S,
    3. Bourgeat P, et al

    . A normalisation framework for quantitative brain imaging; application to quantitative susceptibility mapping. In: 2017 IEEE 14th International Symposium on Biomedical Imaging (ISBI 2017), Melbourne, Australia. April 18–21, 2017:97–100 doi:10.1109/ISBI.2017.7950477

    CrossRef
28. 28.↵
    1. Avants BB,
    2. Tustison NJ,
    3. Song G, et al

    . A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 2011;54:2033–44 doi:10.1016/j.neuroimage.2010.09.025 pmid:20851191

    CrossRefPubMed
29. 29.↵
    1. Iturriaga C,
    2. Pineda M,
    3. Fernández-Valero EM, et al

    . Niemann-Pick C disease in Spain: clinical spectrum and development of a disability scale. J Neurol Sci 2006;249:1–6 doi:10.1016/j.jns.2006.05.054 pmid:16814322

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Walterfang M,
    2. Siu R,
    3. Velakoulis D

    . The NUCOG: validity and reliability of a brief cognitive screening tool in neuropsychiatric patients. Aust N Z J Psychiatry 2006;40:995–1002 doi:10.1080/j.1440-1614.2006.01923.x pmid:17054568

    CrossRefPubMed
31. 31.↵
    1. Rush AJ Jr.,
    2. First MB,
    3. Blacker D

    , eds. Handbook of Psychiatric Measures. 2nd ed. American Psychiatric Publishing; 2008:84–86
32. 32.↵
    1. Smith SM,
    2. Nichols TE

    . Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44:83–98 doi:10.1016/j.neuroimage.2008.03.061 pmid:18501637

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Winkler AM,
    2. Ridgway GR,
    3. Webster MA, et al

    . Permutation inference for the general linear model. Neuroimage 2014;92:381–97 doi:10.1016/j.neuroimage.2014.01.060 pmid:24530839

    CrossRefPubMed
34. 34.↵
    1. Spence H,
    2. McNeil CJ,
    3. Waiter GD

    . The impact of brain iron accumulation on cognition: a systematic review. PLoS One 2020;15:e0240697 doi:10.1371/journal.pone.0240697 pmid:33057378

    CrossRefPubMed
35. 35.↵
    1. Khattar N,
    2. Triebswetter C,
    3. Kiely M, et al

    . Investigation of the association between cerebral iron content and myelin content in normative aging using quantitative magnetic resonance neuroimaging. Neuroimage 2021;239:118267 doi:10.1016/j.neuroimage.2021.118267 pmid:34139358

    CrossRefPubMed
36. 36.↵
    1. Benjamini Y,
    2. Hochberg Y

    . Controlling the false discovery rate: a practical and powerful approach to multiple testing. Royal Statistical Society: Series B (Methodological) 1995;57:289–300 doi:10.1111/j.2517-6161.1995.tb02031.x

    CrossRefPubMed
37. 37.↵
    RStudio Team. RStudio: Integrated Development Environment for R. 2020. http://www.rstudio.com/. Accessed December 6, 2021
38. 38.↵
    1. Revelle W

    . psych: Procedures for Psychological, Psychometric, and Personality Research. September 22, 2021. https://CRAN.R-project.org/package=psych. Accessed December 6, 2021
39. 39.↵
    1. Wei T,
    2. Simko V,
    3. Levy M, et al

    . corrplot: Visualization of a Correlation Matrix. November 18, 2021. https://CRAN.R-project.org/package=corrplot. Accessed December 6, 2021
40. 40.↵
    1. Conigrave J

    . corx: Create and Format Correlation Matrices. June 30, 2020. https://CRAN.R-project.org/package=corx. Accessed December 6, 2021
41. 41.↵
    1. Wickham H,
    2. Averick M,
    3. Bryan J, et al

    . Welcome to the tidyverse. J Open Source Softw 2019;4:1686 doi:10.21105/joss.01686

    CrossRefPubMed
42. 42.↵
    1. Wickham H,
    2. Bryan J

    . readxl: Read Excel Files. 2019. https://CRAN.R-project.org/package=readxl. Accessed December 6, 2021
43. 43.↵
    1. Wickham H

    . ggplot2: Elegant Graphics for Data Analysis. 2016. https://ggplot2.tidyverse.org. Accessed December 6, 2021
44. 44.↵
    1. Wickham H,
    2. François R,
    3. Henry L, et al

    . dplyr: A Grammar of Data Manipulation. 2021. https://CRAN.R-project.org/package=dplyr. Accessed December 6, 2021
45. 45.↵
    1. Deistung A,
    2. Schweser F,
    3. Reichenbach JR

    . Overview of quantitative susceptibility mapping. NMR Biomed 2017;30:e3569 doi:10.1002/nbm.3569 pmid:27434134

    CrossRefPubMed
46. 46.↵
    1. Langkammer C,
    2. Schweser F,
    3. Krebs N, et al

    . Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 2012;62:1593–99 doi:10.1016/j.neuroimage.2012.05.049 pmid:22634862

    CrossRefPubMed
47. 47.↵
    1. Duyn JH,
    2. Schenck J

    . Contributions to magnetic susceptibility of brain tissue. NMR Biomed 2017;30:23546 doi:10.1002/nbm.3546

    CrossRef
48. 48.↵
    1. Walterfang M,
    2. Patenaude B,
    3. Abel LA, et al

    . Subcortical volumetric reductions in adult Niemann-Pick disease type C: a cross-sectional study. AJNR Am J Neuroradiol 2013;34:1334–40 doi:10.3174/ajnr.A3356 pmid:23237858

    Abstract/FREE Full Text
49. 49.↵
    1. Walterfang M,
    2. Fahey M,
    3. Desmond P, et al

    . White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. Neurology 2010;75:49–56 doi:10.1212/WNL.0b013e3181e6210e pmid:20484681

    Abstract/FREE Full Text
50. 50.↵
    1. Benarroch EE

    . Pulvinar. Neurology 2015;84:738–47 doi:10.1212/WNL.0000000000001276 pmid:25609762

    Abstract/FREE Full Text
51. 51.↵
    1. Salsano E,
    2. Umeh C,
    3. Rufa A, et al

    . Vertical supranuclear gaze palsy in Niemann-Pick type C disease. Neurol Sci 2012;33:1225–32 doi:10.1007/s10072-012-1155-1 pmid:22810120

    CrossRefPubMed
52. 52.↵
    1. Reddy JV,
    2. Ganley IG,
    3. Pfeffer SR

    . Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling. PLoS One 2006;1:e19 doi:10.1371/journal.pone.0000019 pmid:17183645

    CrossRefPubMed
53. 53.↵
    1. Devos D,
    2. Cabantchik ZI,
    3. Moreau C, et al

    ; FAIRPARK-II and FAIRALS-II studygroups. Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis. J Neural Transm (Vienna) 2020;127:189–203 doi:10.1007/s00702-019-02138-1 pmid:31912279

    CrossRefPubMed
54. 54.↵
    1. Hung YH,
    2. Lotan A,
    3. Yeshurun S, et al

    . Iron chelation by deferiprone does not rescue the Niemann-Pick disease type C1 mouse model. Biometals 2020;33:87–95 doi:10.1007/s10534-020-00233-5 pmid:32100150

    CrossRefPubMed
55. 55.↵
    1. Chen J,
    2. Gong NJ,
    3. Chaim KT, et al

    . Decompose quantitative susceptibility mapping (QSM) to sub-voxel diamagnetic and paramagnetic components based on gradient-echo MRI data. Neuroimage 2021;242:118477 doi:10.1016/j.neuroimage.2021.118477 pmid:34403742

    CrossRefPubMed